Existing evidences implied that AMPK activation inhibits cancer cells through regulating its downstream signals, including activating pro-apoptotic p53 cascades, and inactivating pro-cancerous mTOR complex 1 (mTORC1) signaling [16]. The gene discussed is TP53; the disease is cancer.